Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison
Author:
Publisher
BMJ
Subject
General Medicine
Reference49 articles.
1. Reviewing the ICS 2002 terminology report: the ongoing debate;Abrams;Neurourol Urodyn,2009
2. Comorbidities associated with overactive bladder;Brown;Am J Manag Care,2000
3. Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey;Liberman;Urology,2001
4. Predictors for falls and fractures in the longitudinal aging study Amsterdam;Tromp;J Bone Miner Res,1998
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Pharmacoeconomic feasibility of using Mirabegron in patients with overactive bladder;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2021-04-24
2. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews;BMJ;2021-03-29
3. Real-World Effects of Mirabegron in Patients with Chronic Neurogenic Detrusor Overactivity – A Retrospective Cohort Study;Research and Reports in Urology;2020-05
Real-World Effects of Mirabegron in Patients with Chronic Neurogenic Detrusor Overactivity – A Retrospective Cohort Study
4. Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review;International Journal of Molecular Sciences;2020-01-30
5. Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost;Journal of Urology;2020-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3